Nivolumab With Ipilimumab for Small Cell Lung Cancer

0 Views
administrator
administrator
07/14/23

Matthew D. Hellmann, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the CheckMate-032 study, which explored nivolumab (Opdivo) with or without ipilimumab (Yervoy) for patients with small cell lung cancer (SCLC).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next